Ocrevus, Konzentrat zur Herstellung einer Infusionslösung
7680661850010
CH-66185
Konzentrat
Associated product:
OCREVUS conc perf 300 mg/10 ml flac 10 ml
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ocrelizumabum
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
trehalosum dihydricum
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
3.6 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 5054.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2018
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 66185
- Drug name
- Ocrevus, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AG08
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 20/09/2017
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- OCREVUS conc perf 300 mg/10 ml flac 10 ml
- Description (DE)
- OCREVUS Inf Konz 300 mg/10 ml Durchstf 10 ml
- Market launch
- 20/09/2017
- Narcotic (BTM)
- No